Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07136233 · ClinicalTrials.gov registry record · NA
Impact of Benefit Inserts on Health Plan Selection and Utilization Among Renewing Covered California Members
A NA study of Outreach Intervention, sponsored by Covered California.
- Active
- Registry status
- NA
- Development phase
- 1,600,000
- Enrollment target
- 1
- Study location
NCT07136233: Active NA study of Outreach Intervention, sponsored by Covered California.
NCT07136233 is a NA study of Outreach Intervention that is active but no longer recruiting, run by Covered California. The registered enrollment target is 1,600,000 participants, above the 1,376-participant average among 58,714 other NA trials with a reported enrollment target (116179% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07136233, a NA study of Outreach Intervention, is active but no longer recruiting, sponsored by Covered California.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,600,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to evaluate the impact of an informational flyer insert on health plan selection and health care utilization among Covered California renewing members during the 2025 plan year. The flyer highlights the enhanced Silver plan benefits, which were expanded in 2025 to include all enrollees, regardless of income level. Key benefits include $0 deductibles, lower monthly premiums, free preventive visits, and reduced costs for primary care, emergency care, and medications. The main questions the study seeks to answer are: * Does the informational flyer help overcome barriers that prevent consumers from switching to more beneficial plans? * Does the flyer encourage current Silver Plan enrollees to increase health care utilization, such as preventive visits, primary care, and medication usage, by highlighting enhanced benefits like $0 deductible and lower costs? To address these questions, researchers will compare outcomes between households that receive the flyer insert and those that do not. Covered California's administrative data will provide individual-level information on plan selection, while claims data will offer insights into healthcare utilization patterns. This approach will help determine the effectiveness of targeted communication in driving selection of more beneficial plan and improving healthcare utilization.
Primary Outcome
A binary indicator for whether a consumer enrolled in an Enhanced CSR plan in 2025 open enrollment period.
Conditions Studied
Interventions
- BEHAVIORAL Informational Flyer Insert on Enhanced Silver Plan Benefits
Study Locations (1)
California
- Covered California - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600,000 participants |
| Start Date | 2024-10-04 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What the registry record for NCT07136233 still lists
NCT07136233 is an interventional study that assigns participants to a tested intervention. Its 1,600,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,376-participant average among 58,714 other NA trials with a reported enrollment target (116179% higher).
The record links to 1 condition, with Outreach Intervention appearing as the primary indexed condition, and to 1 intervention - of which Informational Flyer Insert on Enhanced Silver Plan Benefits is the first listed.
NCT07136233 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07136233 about?
NCT07136233 is a clinical study titled "Impact of Benefit Inserts on Health Plan Selection and Utilization Among Renewing Covered California Members". The study aims to evaluate the impact of an informational flyer insert on health plan selection and health care utilization among Covered California renewing members during the 2025 plan year. The flyer highlights the enhanced Silver plan benefits, which were expanded in 2025 to include all enrollee...
What is the current status of trial NCT07136233?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,600,000 participants. The study started on 2024-10-04. Estimated completion is 2026-07-30.
What conditions does trial NCT07136233 study?
This clinical trial studies the following conditions: Outreach Intervention.
What interventions are being tested in trial NCT07136233?
The interventions under investigation include: Informational Flyer Insert on Enhanced Silver Plan Benefits (BEHAVIORAL).
Who is sponsoring clinical trial NCT07136233?
This trial is sponsored by Covered California, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07136233 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07136233's enrollment target sits among peer trials
1,600,000 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03813862 · 2,000,000 participants
Observational Pharmaco-Epidemiology Research & Analysis
- NCT06057181 · 2,000,000 participants
Helix Research Network
- NCT07022951 · 1,200,000 participants
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI